ANL 29.68 Increased By ▲ 1.38 (4.88%)
ASC 20.22 Decreased By ▼ -0.03 (-0.15%)
ASL 24.98 Decreased By ▼ -0.12 (-0.48%)
BOP 8.28 Increased By ▲ 0.03 (0.36%)
BYCO 10.31 Increased By ▲ 0.17 (1.68%)
FCCL 22.20 Increased By ▲ 0.28 (1.28%)
FFBL 26.70 Decreased By ▼ -0.05 (-0.19%)
FFL 20.25 Increased By ▲ 0.15 (0.75%)
FNEL 9.03 Increased By ▲ 0.09 (1.01%)
GGGL 27.40 Increased By ▲ 1.15 (4.38%)
GGL 45.63 Increased By ▲ 3.01 (7.06%)
HUMNL 7.28 Increased By ▲ 0.08 (1.11%)
JSCL 21.85 Increased By ▲ 0.45 (2.1%)
KAPCO 39.60 Increased By ▲ 0.41 (1.05%)
KEL 3.91 Increased By ▲ 0.05 (1.3%)
MDTL 3.64 Increased By ▲ 0.10 (2.82%)
MLCF 45.54 Increased By ▲ 1.54 (3.5%)
NETSOL 161.80 Increased By ▲ 3.29 (2.08%)
PACE 7.45 Increased By ▲ 0.25 (3.47%)
PAEL 33.30 Increased By ▲ 0.50 (1.52%)
PIBTL 11.15 Increased By ▲ 0.11 (1%)
POWER 9.20 Increased By ▲ 0.09 (0.99%)
PRL 23.90 Increased By ▲ 0.95 (4.14%)
PTC 12.12 Increased By ▲ 0.29 (2.45%)
SILK 1.79 Increased By ▲ 0.03 (1.7%)
SNGP 50.60 Increased By ▲ 1.10 (2.22%)
TELE 17.04 Increased By ▲ 1.24 (7.85%)
TRG 162.50 Increased By ▲ 4.30 (2.72%)
UNITY 40.80 Increased By ▲ 0.80 (2%)
WTL 3.67 Increased By ▲ 0.15 (4.26%)
BR100 5,189 Increased By ▲ 64.21 (1.25%)
BR30 26,249 Increased By ▲ 598.06 (2.33%)
KSE100 47,758 Increased By ▲ 305.07 (0.64%)
KSE30 19,110 Increased By ▲ 124.84 (0.66%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
23,529
6724hr
Pakistan Cases
1,043,277
3,58224hr
7.19% positivity
Sindh
387,261
Punjab
358,387
Balochistan
30,627
Islamabad
88,344
KPK
145,306

One good news out of 2020 has been the performance of the pharmaceutical sector. Players across the industry posted profitability in the green, a refreshing change in an otherwise solemn year.

Abbott Laboratories (Pakistan) Limited (PSX: ABOT) saw one of the highest growth rates in its topline at 17 percent in almost a decade, clocking in at over Rs35 billion. Historically, a major part of its revenue is generated locally, while exports form an insignificant part. While a sales breakdown for CY20 is not yet available, it is safe to assume that the trend has maintained. Another trend is that most of the revenue and profitability historically has been contributed by the adult nutritional segment.

However, the rising topline is not the sole reason for the growth and profitability; it has also been complimented by a reduction in costs. Given that the pharmaceutical industry largely relies on imported raw materials, exchange rate fluctuation plays a significant role. This is also evident in fluctuation of cost of production year on year. CY19 saw notable exchange rate fluctuation post the general elections of 2018, combined with the general inflationary pressures. The onset of Covid-19 at the beginning of 2020 was a blessing in disguise, as the exchange rate stabilized to a certain extent, aiding in cost reduction.

As per the reports by IQVIA - an American information and research company, Pakistan’s pharmaceutical industry has been one of the fastest growing industry in the world in 2020, and Abbott Laboratories numbers for the year provide testament to this.